Skip to main content
. 2022 Jan 13;15:803302. doi: 10.3389/fncel.2021.803302

TABLE 1.

Clinical characteristics of two patients with IHPRF3.

Patient F6331-1 F6331-4
Age (year), Sex 14, F 10, F
Birth evaluation
°Birth Weight (centile) 3,990 g (p90) 3,850 g (p50)
°Birth Length (centile) 51 cm (p75) 48 cm (p50)
°Apgar Scores (1st/5th min) 10/10 8/9
Last evaluation
°Weight (centile) 53.5 kg (p90) 33.5 kg (p75)
°Height (centile) 164 cm (p > 97) 133 cm (p50)
°Head circumference (centile) 55 cm (p96) 53.5 cm (p < 96)
Development
°Regression No yes
°Seizures no yes
°Speech Few words Non-verbal
°Neuropsychomotor development Severe delay Severe delay
°Cognitive Severe delay Severe delay
°ASD yes yes
°ID yes yes
°Hypotonia yes no
°Motor Motor delay Motor dyspraxia
EEG No Diffuse bilateral slow waves with multifocal epileptiform discharges
MRI Volumetric reduction and abnormal T2 signal hyperintensity in white matter Volumetric reduction and abnormal T2 signal hyperintensity in white matter
Facial dismorphism Deep-set eyes, prominent nasal bridge, accentuated Cupid’s bow of the upper lip, high palate, widely spaced teeth; bitemporal narrowing Deep-set eyes, prominent nasal bridge, accentuated Cupid’s bow of the upper lip, high palate, widely spaced teeth, bitemporal narrowing
Other features Prominent digit pads prominent digit pads, brachydactyly of the 4th and 5th toes and hypoplastic nails
Metabolic alterations dyslipdemia and hypothyroidism dyslipdemia and hypothyroidism

ASD, autism spectrum disorder; ID, intellectual disability; EEG, electroencephalogram; MRI, magnetic resonance imaging.